Head-to-head · Cost-Efficiency Index
Invigor Medical vs Care Bare Rx
Two GLP-1 programs on the bench, scored on the same six factors. Here's how their real cost of ownership compares — and which one we'd start with.
Invigor Medical
Value shoppers who want competitive pricing on both molecules plus a wider wellness/hormone program on one account.
Visit Invigor MedicalCare Bare Rx
People consolidating several telehealth needs on one verified platform who are willing to start an intake to find out what GLP-1 treatment actually costs.
Visit Care Bare RxThe verdict
Invigor Medical takes it, leading the Cost-Efficiency Index 88 to 80. Solid mid-market cost on both molecules from an established operator — good value if you also want a broader metabolic and hormone catalog. Care Bare Rx still earns a B− — People consolidating several telehealth needs on one verified platform who are willing to start an intake to find out what GLP-1 treatment actually costs.
Worth knowing either way: our overall #1 pick is CoreAge Rx (Cost-Efficiency Index 94/100 — the top of the board). See how it stacks up: CoreAge Rx vs Invigor Medical.
Factor by factor
Both providers scored on our six Cost-Efficiency Index factors. The stronger side on each row is marked in teal.
Normalized Cost/Month
Price Transparency
Nationwide Access
Formulation Options
Clinical Oversight
Contract Flexibility
Pricing, coverage & formulary
The disclosed facts behind the scores. Lower price wins its row (teal).
| Spec | Invigor Medical | Care Bare Rx |
|---|---|---|
| Cost-Efficiency Index | 88/100 | 80/100 |
| Semaglutide / mo | $199/mo | Not disclosed |
| Tirzepatide / mo | $339/mo | Not disclosed |
| Semaglutide / yr (modeled) | $2,388 | — |
| Tirzepatide / yr (modeled) | $4,068 | — |
| Coverage | Not disclosed | Multi-state |
| Oral / sublingual | No | Yes |
| Brand-name access | Compounded only | Yes |
| Rank on the board | #2 | #25 |
Invigor Medical
88/100Where the value is
- Competitive mid-market pricing on both semaglutide and tirzepatide
- Long-running operator with a broad catalog that can consolidate spend
- Both molecules published up front for easy cost modeling
The tradeoffs
- Does not publish an explicit states-served list, so access is a variable in the model
- Compounded only
Care Bare Rx
80/100Where the value is
- LegitScript-certified and HIPAA-compliant, with both oral (Rybelsus, oral tirzepatide) and injectable options
- One platform for weight loss plus hair, TRT, sexual health and NAD+ if you want to consolidate care
The tradeoffs
- No published pricing — you can't model monthly or annual cost until you're inside the intake funnel
- No named clinicians, founding year or parent company disclosed, so transparency is thin
Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the Cost-Efficiency Index. Pricing, states and verification reflect each provider's public disclosures at last review; prices change — confirm on the provider's site. Not medical advice. See our disclosure.